inflammation and glp-1 Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced GLP-1 Receptor Agonists in Chronic

Are There Any Potential Side Effects Or Precautions

Many people with overweight or obesity who lose weight have a tendency to regain all or some weight over time

Originally developed to manage type 2 diabetes, GLP-1s have gained recognition for their efficacy in promoting weight loss by mimicking the actions of the glucagon-like peptide-1 hormone, which regulates appetite and insulin secretion

In recent years, there has been a substantial body of research highlighting the neuroprotective potential of phytochemicals and antioxidants, as well as their positive impact on the prevention of neurodegenerative disorders (Gandhi and Abramov 2012